PlainPharmaWatch

CMS Open Payments · Program Year 2024

BioFire Diagnostics, LLC

BioFire Diagnostics, LLC reported $3,067,163.01 across General Payments, Research, and Ownership to 11 physicians and teaching hospitals across 300 transactions.

See the rankings → How this is sourced
$3.1M
All-tracks total
300
Transactions
11
Recipients
−$198.5K
General Payments vs PY2023

BioFire Diagnostics, LLC reported $3,067,163.01 across all CMS Open Payments tracks (General + Research + Ownership) to 11 physicians and teaching hospitals in Program Year 2024 - ranking #358 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $2,594.95, averaging $278.8K per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer biofire-diagnostics-llc BioFire Diagnostics, LLC

$3.1M · #358/1,925 · 0.0% industry · PY2024

  • TOT $3.1M
  • RANK #358
  • SHARE 0.0%
  • TXN 300
  • RCP 11
  • CAT 2
  • GEN $2.6K
  • ΔGEN −$198.5K
  • TOP1 45.5%
  • PY 2024

Volume peers

Nearest volume peer: Array Biopharma Inc ($3.1M)

Amneal Pharmaceuticals LLC$3.1MNeuraMedica Inc.$3.1MArray Biopharma Inc$3.1MBioFire Diagnostics, LLC (th…$3.1MVisby Medical, Inc.$3.0M
All-tracks payment totals near BioFire Diagnostics, LLC (CMS Open Payments PY2024)

BioFire Diagnostics, LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

BioFire Diagnostics, LLC's CMS-reported General Payments decreased by $198.5K (−98.7%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2022: BIOFIRE DIAGNOSTICS, LLCPY2023: BIOFIRE DIAGNOSTICS, LLCPY2024: BioFire Diagnostics, LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$201.1KPY2024$2.6K
PY2023
$201,095.40
PY2024
$2,594.95

What the Data Shows for BioFire Diagnostics, LLC

Averaging $10.2K per transaction and $278.8K per recipient, BioFire Diagnostics, LLC's Program Year 2024 total comes to $3,067,163.01 across 300 transactions and 11 physicians and teaching hospitals. In the CMS Open Payments database that is good for rank #358 of 1,925 companies, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

"Consulting Fee" leads the 2-category general-payment breakdown below at $2.0K (78.2% of General Payments, 3 transactions) - see our methodology for how research and ownership payments are reported separately.

General Payment Breakdown by Type

"Consulting Fee" leads BioFire Diagnostics, LLC's 2-category general-payment breakdown at $2.0K, 78.2% of the reported total.

How BioFire Diagnostics, LLC divides its payments

General-payment categories, ordered by reported total

1. Consulting Fee$2.0K2. Food and Beverage$564.95
Payment Type Amount Transactions
Consulting Fee $2.0K 3
Food and Beverage $564.95 8

Recipient Concentration in General Payments

The five largest recipient relationships account for $2,484.67 (95.8%) of $2,594.95 in this company's General Payments records across 9 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for BioFire Diagnostics, LLC

The five named recipients with the highest reported General Payments from this company

Christina Muzny$1.2KJeffrey Klausner$850.00Larissa May$300.25Kevin Messacar$105.42Ferric Fang$49.00
  1. 1

    Christina Muzny

    $1,180.00 across 2 reported transactions

  2. 2

    Jeffrey Klausner

    $850.00 across 1 reported transactions

  3. 3

    Larissa May

    $300.25 across 2 reported transactions

  4. 4

    Kevin Messacar

    $105.42 across 1 reported transactions

  5. 5

    Ferric Fang

    $49.00 across 1 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as BioFire Diagnostics, LLC's, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about BioFire Diagnostics, LLC.

Menarini Silicon Biosystems, Inc.

HHI 3287

Grace Medical, Inc.

HHI 3285

Ortho Organizers, Inc.

HHI 3318

Secura Bio, Inc.

HHI 3279

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with BioFire Diagnostics, LLC.

Showing 6 of 1,924 companies with CMS-reported payment data.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download BioFire Diagnostics, LLC's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.